The Limited Times

Now you can see non-English news...

Recommendation: The country should be equipped with Ramadan Siberia for the winter Israel today

2020-07-17T18:24:51.016Z


| healthThe Corona National War Information and Knowledge Center has called for a drug that studies suggest is effective in treating Corona Ramadsibir Capitals // Photo: Gettyimages The Corona Center for National Information and Knowledge for the War announced yesterday that the country must be equipped with a large-scale remedy for remedy. "It should be noted that although the drug shows only partial ...


The Corona National War Information and Knowledge Center has called for a drug that studies suggest is effective in treating Corona

  • Ramadsibir Capitals // Photo: Gettyimages

The Corona Center for National Information and Knowledge for the War announced yesterday that the country must be equipped with a large-scale remedy for remedy. "It should be noted that although the drug shows only partial efficacy for coronary heart disease, at present it is the most effective treatment. 

As first reported in "Israel Today", this week is expected to arrive in Israel a stock of the drug Ramadsibir, the only drug approved in Europe for the treatment of corona. This is after the stock has almost run out recently. 

It should be noted that Israel was one of the first countries to reach the drug. The drug, manufactured by Giliad, will now arrive in the country according to the availability of stock worldwide, and the distribution between the countries is made according to the state of the epidemic (epidemic) in each country.

Last month, a study was published on the drug - conducted in hospitalized patients in a critical condition and included a control group - which found that providing treatment for five days increased patients' chances of improving disease symptoms and indices by 65% ​​- hospital discharge and increased blood oxygen levels. 

Source: israelhayom

All life articles on 2020-07-17

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.